Hereditary multiple exostosis

Acta Orthopaedica Belgica

Volumn 79, Issue 6, 2013, Pages 597-607

  Ryckx, Andries ^a   Somers, Jan F A ^b   Allaert, Lieven ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Jan Yperman Hospital   (Belgium)

^c FACS ^*  (Belgium)

Author keywords

Hereditary Multiple Exostosis; Review

Indexed keywords

DRUG DERIVATIVE; EXOSTOSIN 1; EXOSTOSIN-1; HEPARIN; HEPARIN PROTEOGLYCAN; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEOGLYCAN; SONIC HEDGEHOG PROTEIN;

ANIMAL; ANKLE; ARM; BIOSYNTHESIS; CARTILAGE CELL; CELL PROLIFERATION; ELBOW; FOREARM; GENETICS; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; LEG; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY; REVIEW;

ANIMALS; ANKLE; ANKLE JOINT; CELL PROLIFERATION; CHONDROCYTES; ELBOW; EXOSTOSES, MULTIPLE HEREDITARY; FOREARM; HEDGEHOG PROTEINS; HEPARIN; HUMANS; LOWER EXTREMITY; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEOGLYCANS; UPPER EXTREMITY;

EID: 84891547380     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Abdel MP, Papagelopoulos PJ, Morrey ME et al. Surgical management of 121 benign proximal fibula tumors. Clin Orthop Relat Res 2010; 468 : 3056-3062.
2. Ahmed AR, Tan TS, Unni KK et al. Secundary chondrosarcoma in osteochondroma : report of 107 patients. Clin Orthop Relat Res 2003; 411 : 193-206.
3. Akita S, Murase T, Yonenobu K et al. Long-term results of surgery for forearm deformities in patients with multiple cartilaginous exostoses. J Bone Joint Surg 2007; 89-A : 1993-1999.
4. Ayerza MA, Abalo E, Aponte-Tinao L, Muscolo DL. Endoscopic resection of symptomatic osteochondroma of the distal femur. Clin Orthop Relat Res 2007; 459 : 150- 153.
5. Benoist-Lasselin C, de Margerie E, Gibbs L et al. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients. Bone 2006; 39 : 17-26.
6. Bernard MA, Hall CE, Hogue DA. Diminished levels of the tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Cell Mot Cytoskeleton 2001; 48 : 149-162.
7. Bornemann DJ, Duncan JE, Staatz W, Selleck S, Warrior R. Abrogation of heparan sulfate synthesis in Drosophilia disrupts the Wingless, Hedgehog and decapentaplegic signaling pathways. Development 2004; 131 : 1927-1938.
8. Bottner F, Rodl R, Kordish I et al. Surgical treatment of symptomatic osteochondroma : a three to eight-year follow up study. J Bone Joint Surg 2003; 85 : 1161-1166.
9. Bovée JV, Cleton-Jansen AM, Wuyts W et al. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet 1999; 65 : 689-698.
10. Bovée JV, Hogendoorn PC, Wunder JS, Alman BA. Cartilage tumours and bone development : molecular pathology and possible therapeutic targets. Nature Rev Cancer 2010; 10 : 481-488.
11. Cardelia JM, Dormans JP, Drummond DS et al. Proximal fibular osteochondroma with associated peroneal nerve palsy : a review of six cases. J Pediatr Orthop 1995; 15 : 574-577.
12. Carey DJ. Syndecans : multifunctional cell-surface co-receptors. Biochem J 1997; 327 : 1-16.
13. Cates H, Burgess RC. Incidence of brachydactyly and hand exostosis in multiple hereditary exostosis. Am J Hand Surg 1991; 16 : 127-132.
14. Chin KR, Kharrazi FD, Miller BS, Mankin HJ, Gebhardt MC. Osteochondromas of the distal aspect of the tibia or fibula. Natural history and treatment. J Bone Joint Surg 2000; 82-A : 1269-1278.
15. Felix NA, Mazur JM, Loveless EA. Acetabular dysplasia associated with hereditary multiple exostoses. A case report. J Bone Joint Surg 2000; 82-B : 555-557.
16. Hameetman L, Bovée JV, Taminiau AH, Kroon HM, Hogendoorn PC. Multiple osteochondromas : clinicopathological and genetic spectrum and suggestions for clinical management. Hered Cancer in Clin Practice 2004; 2 : 161-173.
17. Hecht JT, Hogue D, Strong LC et al. Hereditary multiple exostosis and chondrosarcoma : linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet 1995; 56 : 1125-1131.
18. Hennekam RC. Hereditary multiple exostoses. J Med Gen 1991; 28 : 262-266.
19. Hilton MJ, Gutiérrez L, Martinez DA, Wells DE. EXT1regulates chondrocyte proliferation and differentiation during enchondral bone development. Bone 2005; 36 : 379-386.
20. Hosalkar H, Greenberg J, Gaugler RL, Garg S, Dormans JP. Abnormal scarring with keloid formation after osteochondroma excision in children with multiple hereditary exostoses. J Pediatr Orthop 2007; 27 : 333-337.
21. Jaffe H. Hereditary multiple exostosis. Arch Pathol Lab Med 1943; 36 : 335-357.
22. Jahhs MH, Olives R. The foot and ankle in multiple hereditary exostoses. Foot Ankle 1980; 1 : 128-142.
23. Roach JW, Klatt JW, Faulkner ND. Involvement of the spine in patients with multiple hereditary exostoses. J Bone Joint Surg 2009; 91-A : 1942-1948.
24. Johansson M, Jin Y, Mandahl N et al. Cytogenetic analysis of the short-term cultured squamous cell carcinomas of the lung. Cancer Genet Cytogenet 1995; 81 : 46-55.
25. Stieber JR, Dormans JP. Manifestations of hereditary multiple exostoses. J Am Ac Orthop Surg 2005; 13 : 110- 120.
26. Karibe T, Fukui H, Sekikawa A, Shiratori K, Fujimori T. EXTL 3 promoter methylation down-regulates EXTL 3 and heparin sulphate expression in mucinous colorectal cancers. J Pathol 2008; 216 : 32-42.
27. Kim BT, Kitagawa H, Tamura J et al. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4-Nacetylglucosaminyltransferases that likely are involved in heparan sulfate/heparin biosynthesis. Proc Natl Acad Sci USA 2001; 98 : 7176-7181.
28. Kitagawa H, Shimakawa H, Sugahara K. The tumor suppressor EXT-like gene EXTL2 encodes an alpha1,4-Nacetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan- protein linkage region. The key enzyme for the chain initiation of heparan sulfate. J Biol Chem 1999; 274 : 13933-13937.
29. Kronenberg H. Developmental regulation of the growthplate. Nature 2003; 423 :332-336.
30. Rozeman LB, de Bruijn IH, Bacchini P et al. Dedifferentiated peripheral chondrosarcomas : regulation of EXTdownstream molecules and differentiation related genes. Mod Path 2009; 22 : 1489-1498.
31. Le Merrer M, Legeai-Mallet L, Jeannin PM et al. A gene for hereditary multiple exostoses maps to chromosome19p. Hum Mol Genet 1994; 3 : 717-722.
32. Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K. The putative tumour suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparinsulfate. J Biol Chem 1998; 273 : 26265-26268.
33. Lüdecke HJ, Ahn J, Lin X et al. Genomic organization and promoter structure of the human EXT1 gene. Genomics. 1997; 40 : 351-354.
34. Malagon V. Development of hip dysplasia in hereditary multiple exostosis. J Pediatr Orthop 2001; 21 : 205- 211.
35. Masada K, Tsuyuguchi Y, Kawai H et al. Operations for forearm deformity caused by multiple osteochondromas. J Bone Joint Surg 1989; 71-B : 24-29.
36. Matsubara H, Tsuchiya H, Sakurakichi K et al. Correction and lengthening for deformities of the forearm in multiple cartilaginous exostoses. J Orthop Sci 2006; 11 : 459-466.
37. McCormick C, Duncan G, Goutsos KT, Tufaro F. The putative tumor suppressors EXT1 and EXT2 for a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 2000; 97 : 668-673.
38. McCormick C, Leduc Y, Martindale D et al. The putative tumour suppressor EXT1 alters the expression of cell-surface heparin sulfate. Nat Genet 1998; 19 : 158-161.
39. Merchan E, Sanchez Herrera S, Gonzalez JM. Secundary chondrosarcoma. Four cases and review of the literature. Acta Orthop Belg 1993; 59 : 76-80.
40. Mertens F, Rydholm A, Kreicbergs A et al. Loss of chromosome band 8q24 in sporadic osteocartaliginous exostoses. Gen Chrom Cancer 1994; 9 : 8-12.
41. Minina E, Kreschel C, Naski MC, Ornitz DM, Vortkamp A. Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 2002; 3 : 439-449.
42. Minina E, Wenzel HM, Kreschel C et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyteproliferation and differentiation. Development 2001; 128 : 4523-4534.
43. Mootha AK, Saini R, Dhillon M et al. Modified resection technique for proximal fibular osteochondromas. Orthop Traumatol Surg Res 2011; 97 : 569-573.
44. Murase T, Moritomo H, Tada K, Yoshida T. Pseudomallet finger associated with exostosis of the phalanx. Am J Hand Surg 2002; 27 : 817-820.
45. Murphey MD, Choi JJ, Kransdorf MJ, Flemming DJ, Gannon FH. Imaging of osteochondroma : variants and complications with radiologic-pathologic correlation. Radiographics 2000; 20 : 1407-1434.
46. Nadanaka S, Kitagawa H. Heparan sulfate biosynthesis and disease. J Biochem 2008; 144 : 7-14.
47. Noonan KJ, Levenda A, Snead J, Feinberg JR, Mih A. Evaluation of the forearm in untreated adult subjects with multiple hereditary osteochondromatosis. J Bone Joint Surg 2002; 84-A : 397-403.
48. Norton WH, Ledin J, Grandel H, Neumann CJ. HSPG synthesis in by zebrafish Ext2 and Extl3 is required for Fgf 10 signalling during limb development. Development 2005; 132 : 4963-4973.
49. Pata G, Nascimbeni R, Di Lorenzo D et al. Hereditary multiple exostoses and juvenile colon carcinoma : a case with a common genetic background ? J Surg Oncol 2009; 100 : 520-522.
50. Pierz KA, Stieber JR, Kusumi K, Dormans JP. Hereditary multiple exostoses : one center's experience and review of etiology. Clin Orthop Relat Res 2002; 401 : 49- 59.
51. Razzaque MS, Soegiarto DW, Chang D, Long F, Lanske B. Conditional deletion of Indian hedgehog from collagen type 2 alpha1-expressing cells results in abnormal endochondral bone formation. J Path 2005; 207 : 453-461.
52. Ropero S, Setien F, Espada J. Epigenetic loss of the familial tumor suppressor gene exostosin-1 (EXT1) disrupts heparin sulfate synthesis in cancer cells. Hum Mol Genet 2004; 13 : 2753-2765.
53. Schmale GA, Conrad EU 3rd, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg 1994; 76-A : 986-992.
54. Seitz S, Rohde K, Bender E et al. Strong indication for a breast cancer susceptibility gene on chromosome 8p12- p22 : Linkage in German breast cancer families. Oncogene 1997; 14 : 741-743.
55. Solomon L. Hereditary multiple exostosis. Am J Hum Gen. 1964; 16 : 351-363.
56. Stickens D, Brown D, Evans GA. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev Dyn 2000; 218 : 452-464.
57. Stickens D, Clines G, Burbee D et al. The EXT2 multiple hereditary exostoses gene defines a family of putative tumor suppressor genes. Nat Genet 1996; 14 : 25-32.
58. Stickens D, Zak BM, Rougier N, Esko JD, Werb Z. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 2005; 132 : 5055-5068.
59. Suzuki H, Emi M, Komiya A et al. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22- 21.3. Genes Chromosomes Cancer 1995; 13 : 168-174.
60. Tiet TD, Hopyan S, Nadesan P et al. Constitutive hedgehog signaling in chondrosarcoma upregulates tumor cel l proliferation. Am J Path 2006; 168 : 321-330.
61. Uchida K, Kurihara Y, Sekiguchi S et al. Spontaneous hemothorax caused by costal exostosis. Eur Respir J 1997; 10 : 735-736.
62. Van Hul W, Wuyts W, Hendrickx J et al. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics 1998; 47 : 230-237.
63. Vasseur M, Fabre O. Vascular complications of osteochondroma. J Vasc Surg 2000; 31 : 532-528.
64. Viala P, Vanel D, Larbi A et al. Bilateral ischiofemoral impingement in a patient with hereditary multiple exostoses. Skeletal Radiol 2012; 41 : 1637-1640.
65. Wicklund CL, Pauli RM, Johnston D, Hecht JT. Natural history study of hereditary multiple exostoses. Am J Med Gen 1995; 55 : 43-46.
66. Wise CA, Clines GA, Massa H, Trask BJ, Lovett M. Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res 1997; 1 : 10-16.
67. Wood VE, Sauser D, Mudge D. The treatment of hereditary multiple exostosis of the upper extremity. Am J Hand Surg 1985; 10 : 505-513.
68. Wuisman PI, Jutte PC, Ozaki T. Secundary chondrosarcomain osteochondromas. Medullary extension in 15 of 45 cases. Acta Orthop Scand 1997; 68 : 396-400.
69. Wuyts W, Van Hul W. Molecular basis of multiple exostoses : mutations in EXT1 and EXT2 genes. Hum Mutat 2000; 15 : 220-227.
70. Wuyts W, Van Hul W, Wauters J et al. Positional cloning of a gene involved in multiple hereditary exostoses. Hum Mol Genet 1996; 10 : 1547-1557.
71. Wuyts W, Van Hul W, Hendrickx J et al. Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet 1997; 6 : 382-389.
72. Yeh SH, Chen PJ, Chen HL et al. Frequent genetic alterations at distal regions of chromosome 1p in hepatocellular carcinomas. Cancer Res 1994; 54 : 4188-4192.